FDA Approved: ADAKVEO — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved ADAKVEO (crizanlizumab) from Novartis as an original biologics license application to reduce the frequency of vaso-occlusive crises in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• ADAKVEO (crizanlizumab)

Snippet

ORIG AP for ADAKVEO (CRIZANLIZUMAB)